SAM
AGIO icon

Sectoral Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Sectoral Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,400
Closed -$503K – 89
2020
Q2 		$503K Buy
+9,400
New +$435K 0.05% 141
2020
Q1 		– Sell
-34,100
Closed -$1.63M – 66
2019
Q4 		$1.63M Sell
34,100
-11,300
-25% -$427K 0.24% 59
2019
Q3 		$1.47M Sell
45,400
-34,600
-43% -$1.43M 0.25% 58
2019
Q2 		$3.99M Buy
80,000
+20,000
+33% +$1.07M 0.48% 58
2019
Q1 		$4.05M Buy
+60,000
New +$3.49M 0.49% 61
2018
Q4 		– Sell
-56,207
Closed -$4.33M – 105
2018
Q3 		$4.33M Buy
+56,207
New +$4.52M 0.46% 58
2018
Q1 		– Sell
-47,799
Closed -$2.73M – 71
2017
Q4 		$2.73M Hold
47,799
– – 0.34% 54
2017
Q3 		$3.19M Sell
47,799
-75,800
-61% -$4.55M 0.41% 48
2017
Q2 		$6.36M Buy
123,599
+72,399
+141% +$3.7M 0.7% 40
2017
Q1 		$2.99M Sell
51,200
-3,700
-7% -$177K 0.35% 46
2016
Q4 		$2.29M Buy
54,900
+2,200
+4% +$115K 0.25% 44
2016
Q3 		$2.78M Buy
52,700
+16,600
+46% +$723K 0.27% 48
2016
Q2 		$1.51M Buy
+36,100
New +$1.78M 0.16% 56

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sectoral Asset Management's AGIO Position: Q3 2020 in Review

Sectoral Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2020, closing a stake of 9,400 shares — an estimated $503K sold.

Sectoral Asset Management first reported a position in AGIO in Q2 2016 and held it in 13 quarters. The position peaked at $6.36M in Q2 2017. 215 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

  • Sectoral Asset Management reported no remaining Agios Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Sectoral Asset Management sold 9,400 Agios Pharmaceuticals shares in Q3 2020, an estimated $503K.
  • Sectoral Asset Management first reported a position in Agios Pharmaceuticals in Q2 2016 and held it in 13 quarters.
  • Sectoral Asset Management's Agios Pharmaceuticals position peaked at $6.36M in Q2 2017.
  • 215 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.